Skip to Content

Brompheniramine / dihydrocodeine / phenylephrine Pregnancy and Breastfeeding Warnings

Brompheniramine / dihydrocodeine / phenylephrine is also known as: Centussin DHC, EndaCof-DH, Poly-Tussin DHC

Brompheniramine / dihydrocodeine / phenylephrine Pregnancy Warnings

Brompheniramine/dihydrocodeine/phenylephrine has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. The Collaborative Perinatal Project monitored 65 first trimester exposures to brompheniramine. Malformations were reported in 10 infants, a statistically significant association. In another 6509 live births, 172 mothers were exposed to Dimetapp (brompheniramine, phenylephrine and phenylpropanolamine). Five infants were born with congenital abnormalities resulting in a somewhat higher frequency than normal. Brompheniramine/dihydrocodeine/phenylephrine is only recommended for use during pregnancy when there are no alternatives and benefit outweighs risk.

See references

Brompheniramine / dihydrocodeine / phenylephrine Breastfeeding Warnings

There are no data on the excretion of brompheniramine or dihydrocodeine into human milk. Small amounts of phenylephrine are secreted in breast milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. "Product Information. Poly-Tussin DHC (brompheniramine/dihydrocodeine/phenylephrine)." Poly Pharmaceuticals Inc, Quitman, MS.

References for breastfeeding information

  1. "Product Information. Poly-Tussin DHC (brompheniramine/dihydrocodeine/phenylephrine)." Poly Pharmaceuticals Inc, Quitman, MS.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.